sulforaphane has been researched along with Liver Cirrhosis in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, MH | 1 |
| Li, JW | 1 |
| Sun, HT | 1 |
| He, SQ | 1 |
| Pang, J | 1 |
1 other study available for sulforaphane and Liver Cirrhosis
| Article | Year |
|---|---|
Sulforaphane inhibits the activation of hepatic stellate cell by miRNA-423-5p targeting suppressor of fused.
Topics: Cell Line; Cell Survival; Depression, Chemical; Down-Regulation; Hepatic Stellate Cells; Humans; Iso | 2019 |